IMA
Imagenebio Inc
NASDAQ · Pharmaceuticals
$6.91
-0.10 (-1.43%)
Open$6.85
Previous Close$7.01
Day High$7.25
Day Low$6.65
52W High$13.71
52W Low$6.26
Volume—
Avg Volume336.5K
Market Cap80.93M
P/E Ratio13.78
EPS$0.71
SectorPharmaceuticals
Analyst Ratings
Buy
7 analysts
Price Target
+74.0% upside
Current
$6.91
$6.91
Target
$12.02
$12.02
$8.98
$12.02 avg
$15.27
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 47.00M | 44.29M | 39.41M |
| Net Income | 6.79M | 4.55M | 5.11M |
| Profit Margin | 14.5% | 10.3% | 13.0% |
| EBITDA | 10.10M | 9.89M | 9.22M |
| Free Cash Flow | 2.61M | 3.33M | 3.29M |
| Rev Growth | -8.8% | -0.9% | +2.4% |
| Debt/Equity | 0.50 | 0.50 | 0.38 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,058.18 | +3.66% | 48.5 | 1.00T |
| JNJ | Johnson & Johnson | $239.99 | +0.93% | 21.6 | 578.21B |
| MRK | Merck & Co. Inc. | $121.93 | +1.82% | 16.6 | 302.63B |
| PFE | Pfizer Inc. | $27.22 | +2.76% | 19.9 | 154.76B |
| BMY | Bristol-Myers Squibb Co | $61.99 | +4.15% | 17.9 | 126.20B |
| ZTS | Zoetis Inc | $127.42 | +0.54% | 21.5 | 56.95B |